Fengyuan Pharmaceutical (000 153)_ A Brief History of Development

Fengyuan Pharmaceutical, do you understand? Fengyuan Pharmaceutical Co., Ltd. is Anhui Fengyuan Pharmaceutical Co., Ltd. Do you know what happened in the development of Fengyuan Pharmaceutical (000 153)? Do you know the brief history of Fengyuan Pharmaceutical (000 153)? Today, the wealth manager will come to meet Fengyuan Pharmaceutical (000 153) for everyone. The following is about

Fengyuan Pharmaceutical (000 153)_ A Brief History of Development. 1August 1997, Anhui Xinli pharmaceutical co., ltd was established.

In June 1998+0 1, the company increased its capital and shares.

It went public in September 2000 and issued 25 million shares.

In June of 20001year, the company invested 25 million yuan to participate in Bengbu City Commercial Bank Co., Ltd., with a shareholding ratio of 17.99%.

In July 2002, Wuwei Pharmaceutical Factory was placed under Fengyuan Group.

From June 5438 to October 2002 10, the company decided to invest 48 million yuan to build two new plastic bottle infusion production lines and 50 million yuan to build two new soft bag infusion production lines in the new factory area of Wuwei Pharmaceutical Factory.

In February 2003, Xinli Pharmaceutical Company changed its name to Fengyuan Pharmaceutical Company.

In July 2004, the pharmaceutical industry acquired 72.6% equity of Fengyuan Pharmacy.

In July 2004, the company and Anhui Fengyuan Tongling Medicine Co., Ltd. * * jointly invested to establish Anhui Fengyuan Tongling Chinese Herbal Pieces Co., Ltd. (the company holds 90% of the shares).

In June 2005, according to the overall requirements of Maanshan city planning, the company decided to relocate Maanshan pharmaceutical factory as a whole.

In August 2006, the overall relocation of Maanshan Pharmaceutical Factory was completed as planned, and the GMP of the whole factory passed the national certification at one time.

In July 2005, the pharmaceutical acquisition entrusted Zhonglian International to acquire 0/00% equity of RT Company.

In June 2005, 80 million bottles of Guzhen infusion project were newly built.

In June 2005, the company formally established "Guzhen Pharmaceutical Factory of Anhui Fengyuan Pharmaceutical Co., Ltd.".

On June 5th+February, 2005, the preparatory group of Fengyuan Logistics Company was established.

From June 5438 to February 2005, the company's share-trading scheme was successfully passed.

In September 2006, the company sold 9 1.59% equity of overseas wholly-owned subsidiary RESISTORTECHNOLOGYLIMITED (RT Company for short).

In September 2006, the logistics company was established.

From June, 5438 to February, 2006, the company invested in the acquisition of 0/00% equity of Anhui Fengyuan Tongling Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Fengyuan Group.

June 5438+October 2007 10, the construction work of Guzhen Pharmaceutical Factory's annual output of 40 million plastic bottles infusion project was completed as scheduled, and two plastic bottle infusion production lines passed the national GMP certification, and the comprehensive production work started as scheduled in March.

In March 2007, the company transferred 80% equity of Anhui Baichun Pharmaceutical Co., Ltd., a holding subsidiary.

In September 2007, the company started team learning for the first time.

From June 5, 2007 to 10, the first-phase drug packaging project of Hefei Fengyuan Pharmaceutical Development Co., Ltd. started construction in Baohe Industrial Park.

On June 5, 2008+10, the company successfully held the first team learning.

In March 2008, the company began to prepare the equity incentive plan.

In July 2008, the second phase of Guzhen Pharmaceutical Factory with an annual output of 40 million bottles of infusion was completed and passed the national GMP certification.

20 10 10 acquired the assets and equipment of former Bengbu Bayi pharmaceutical co., ltd, and invested in the construction of Anhui fengyuan likang pharmaceutical co., ltd.

201111/in October, Fengyuan Guzhen Pharmaceutical Factory was renamed and its wholly-owned subsidiary "Anhui Fengyuan Huaihai Pharmaceutical Company" was established.